View in EDS HTML Full Text PDF Full Text

Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.

Saved in:
Bibliographic Details
Title: Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.
Authors: Eisses, Bertha1 (AUTHOR), van Geel, Jasper J.L.1 (AUTHOR), Brouwers, Adrienne H.2 (AUTHOR), Bensch, Frederike1 (AUTHOR), Elias, Sjoerd G.3 (AUTHOR), Kuip, Evelien J.M.4 (AUTHOR), Jager, Agnes5 (AUTHOR), van der Vegt, Bert6 (AUTHOR), Lub-de Hooge, Marjolijn N.2,7 (AUTHOR), Emmering, Jasper8 (AUTHOR), Arens, Anne I.J.9 (AUTHOR), Zwezerijnen, Gerben J.C.10 (AUTHOR), Vugts, Daniëlle J.10 (AUTHOR), Menke-van der Houven van Oordt, C. Willemien11 (AUTHOR), de Vries, Elisabeth G.E.1 (AUTHOR), Schröder, Carolina P.1,12 (AUTHOR) c.schroder@nki.nl, Bensch, F. (AUTHOR), van Es, S. (AUTHOR), van Essen-Eisses, B. (AUTHOR), Boers, J. (AUTHOR)
Source: Journal of Nuclear Medicine. Oct2024, Vol. 65 Issue 10, p1540-1547. 8p.
Database: Engineering Source
Full text is not displayed to guests.
Description
ISSN:01615505
DOI:10.2967/jnumed.124.267636